Sysmex (OTCMKTS:SSMXY) Sees Strong Trading Volume - Should You Buy?

Key Points

• Sysmex Corporation's shares experienced a significant uptick in trading volume, with 174,739 shares exchanged, an increase of 107% from the previous day.
• Analysts have upgraded Sysmex's rating from "strong sell" to "hold," and the stock currently maintains an average rating of "Hold" according to MarketBeat.
• In its recent quarterly earnings report, Sysmex missed earnings expectations, posting an EPS of $0.05 as opposed to the expected $0.12, while revenue reached $717.09 million against a forecast of $807.27 million.

Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) saw an uptick in trading volume on Tuesday . 174,739 shares traded hands during mid-day trading, an increase of 107% from the previous session's volume of 84,550 shares.The stock last traded at $13.39 and had previously closed at $13.33.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Sysmex from a "strong sell" rating to a "hold" rating in a research note on Thursday, August 14th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of "Hold".

Sysmex Price Performance

The stock has a market capitalization of $8.41 billion, a PE ratio of 26.72 and a beta of 1.15. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.30 and a current ratio of 2.97. The stock's 50 day moving average is $16.05 and its two-hundred day moving average is $17.37.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.12 by ($0.07). The business had revenue of $717.09 million during the quarter, compared to analyst estimates of $807.27 million. Sysmex had a net margin of 9.35% and a return on equity of 10.36%. On average, equities analysts anticipate that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.